Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2160
Peer-review started: November 14, 2022
First decision: February 17, 2023
Revised: February 24, 2023
Accepted: March 14, 2023
Article in press: March 14, 2023
Published online: April 6, 2023
Processing time: 136 Days and 1.1 Hours
The stellate ganglion (SG), as a type of sympathetic ganglion, consists of the sixth and seventh cervical vertebrae and the first thoracic sympathetic ganglia. SG block (SGB) is a minimally invasive injection that aims to inject low-concentration local anesthetics to induce a broad sympathetic blocking effect near the SG. There have been no changes and progress in the clinical application of SGB since the 1830s due to several potential risks, including hematoma from blood vessel injury, hoarseness from recurrent laryngeal nerve injury, and cardiopulmonary arrest. The feasibility and safety of SGB have greatly improved since the appearance of ultrasound-guided SGB. In recent years, SGB has been widely applied in the field of non-anesthesiology sedation, with significant therapeutic effects on pain, immunological diseases, somnipathy, psychological disorders, arrhythmias, and endocrine diseases. The present study reviews the present application of SGB in clinical practice.
Core Tip: Several reviews in the literature have contributed to the therapeutic effect of stellate ganglion block (SGB). The present study reviews the anatomical structure and mechanism of SGB, the advantages of ultrasound localization, and the application of SGB in the treatment of painful diseases, immunological diseases, somnipathy, psychological diseases, arrhythmias, and endocrine diseases.
